A 3D‐Printed Vascular‐Like Perfusion Tumor‐on‐a‐Chip Recapitulates High‐Grade Breast Cancer With in Vivo‐Relevant Drug Resistance
Advanced Healthcare Materials · 2026-08 · 15 (31)
DOI: 10.1002/adhm.71457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 30.07.2026. Verfasst von Geonhui Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: BMF Precision Inc., Maynard, Massachusetts, USA. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Breast Neoplasms, Printing, Three-Dimensional, Lab-On-A-Chip Devices. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BMF Precision Inc..
Abstract (Originalsprache)
Tumor progression and drug resistance in breast cancer are fundamentally governed by a complex microenvironment, characterized by extreme cell densities and associated nutrient/oxygen gradients. Conventional in vitro models often fail to replicate these features due to mass transport limitations in non‐perfused systems. Here, we present a next‐generation tumor‐on‐a‐chip platform engineered via high‐resolution projection micro‐stereolithography (PµSL) to sustain exceptionally high‐density breast cancer tissues (up to 400 million cells/mL) under continuous perfusion. By integrating a vascular‐inspired perfusion architecture with precision‐engineered micropores (∼7 µm), our system enhances nutrient and drug transport compared with traditional non‐perfused 3D cultures. This high‐density microenvironment drives density‐dependent molecular reprogramming of ERα, Ki67, and CTSL2, closely mirroring the gene expression signatures observed in high‐grade patient tumors. Notably, the drug resistance to Elacestrant observed in our high‐density tissues uniquely aligns with clinically reported Cmax concentrations, effectively bridging the gap between in vitro screening and in vivo outcomes. This platform provides a physiologically relevant tool for studying aggressive tumor biology and evaluating personalized therapeutic strategies with high predictive power.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- BMF Precision Inc., Maynard, Massachusetts, USA.
- The University of Hong Kong, Hong Kong, China.
- Materials Innovation Institute for Life Sciences and Energy (MILES), HKU-SIRI, Shenzhen, China.
ORCID-Profile: Nicholas X Fang, Chunguang Xia
Förderung
- BMF Precision Inc.
Zitieren
APA
Lee, G., Sun, B., Fang, N. X., & Xia, C. (2026). A 3D‐Printed Vascular‐Like Perfusion Tumor‐on‐a‐Chip Recapitulates High‐Grade Breast Cancer With in Vivo‐Relevant Drug Resistance. Advanced Healthcare Materials, 15(31). https://doi.org/10.1002/adhm.71457
Vancouver
Lee G, Sun B, Fang NX, Xia C. A 3D‐Printed Vascular‐Like Perfusion Tumor‐on‐a‐Chip Recapitulates High‐Grade Breast Cancer With in Vivo‐Relevant Drug Resistance. Advanced Healthcare Materials. 2026;15(31). doi:10.1002/adhm.71457
BibTeX
@article{Lee2026,
author = {Lee, Geonhui and Sun, Bingjie and Fang, Nicholas X and Xia, Chunguang},
title = {A 3D‐Printed Vascular‐Like Perfusion Tumor‐on‐a‐Chip Recapitulates High‐Grade Breast Cancer With in Vivo‐Relevant Drug Resistance},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {31},
doi = {10.1002/adhm.71457}
}
EUVIMED